Multidrug Resistance Proteins Do Not Predict Benefit of Adjuvant Chemotherapy in Patients With Completely Resected Non-Small Cell Lung Cancer: International Adjuvant Lung Cancer Trial Biologic Program
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-06-2446
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2007
Authors
Publisher
American Association for Cancer Research (AACR)